The modifying effect of 11β-HSD in hypertension of diabetic patients
Authors:
Open Access
- 26 August 2025
- journal article
- editorial
- Published by Springer Nature in Hypertension Research
- Vol. 48 (11) , 3044-3045
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Urinary cortisol-to-cortisone ratio levels modify the association between diabetes and hypertension: a cross-sectional study of 6931 older adultsHypertension Research, 2025
- Progressive 11β-Hydroxysteroid Dehydrogenase Type 2 Insufficiency as Kidney Function DeclinesThe Journal of Clinical Endocrinology & Metabolism, 2024
- 11β-Hydroxysteroid Dehydrogenase Type 1 as a Potential Treatment Target in Cardiovascular DiseasesJournal of Clinical Medicine, 2022
- Serum cortisol-to-cortisone ratio and 11-deoxycortisol are associated with hypertension and blood pressure in Chinese rural population: a cross sectional studyJournal Of Hypertension, 2021
- Classic and Nonclassic Apparent Mineralocorticoid Excess SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2019
- Bioactive Candy: Effects of Licorice on the Cardiovascular SystemFoods, 2019
- Clinical features and therapeutic perspectives on hypertension in diabeticsHypertension Research, 2018
- 11 β ‐Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitusDiabetes, Obesity and Metabolism, 2012
- Tissue-Specific Dysregulation of Cortisol Metabolism in Human ObesityThe Journal of Clinical Endocrinology & Metabolism, 2001
- Tubular Reabsorption Rates as Related to Elevated Glomerular Filtration in Diabetic ChildrenDiabetes, 1983